Ord. No | MOC 2010 | Norway 2010 | Finland 2009 |
---|---|---|---|
 | DTID (% of total use) | DTID (% of total use) | DTID (% of total use) |
1. | Fenoterol, ipratropium 6.11 (33.6 %) | Salmeterol, corticosteroid 11.75 (18.4 %) | Formoterol and other drugs for OAD 10.86 (18.6 %) |
2. | Salmeterol, fluticasone 3.41 (18.8 %) | Salbutamol 11.32 (17.7 %) | Salmeterol and other drugs for OAD 8.78 (15.0 %) |
3. | Aminophylline 2.43 (13.4 %) | Ipratropium bromide 9.51 (14.9 %) | Salbutamol 8.10 (13.9 %) |
4. | Fluticasone 1.98 (10.9 %) | Formoterol, corticosteroid 8.43 (13.2 %) | Fluticasone 5.49 (9.4 %) |
5. | Salbutamol 1.89 (10.4 %) | Montelukast 4.70 (7.3 %) | Budesonide 5.39 (9.2 %) |
6. | Salmeterol 1.45 (8.0 %) | Tiotropium bromide 4.36 (6.8 %) | Montelukast 5.16 (8.8 %) |
7. | Beclomethasone 0.41 (2.2 %) | Fluticasone 3.11 (4.9 %) | Tiotropium bromide 3.50 (6.0 %) |
8. | Theophylline 0.35 (1.9 %) | Terbutaline 2.94 (4.6 %) | Beclomethasone 3.27 (5.6 %) |
9. | Budesonide 0.15 (0.8 %) | Budesonide 2.47 (3.9 %) | Terbutaline 2.05 (3.5 %) |
10. | Othe 0.00 (0.0 %) | Other 5.38 (8.4 %) | Other 5.74 (9.8 %) |
Total (R03) | 18.18 (100.0 %) | 63.97 (100.0 %) | 58.34 (100.0 %) |